Evolent Health A Aktie
6,90
EUR
-0,10
EUR
-1,43
%
7,60
USD
-0,49
USD
-6,06
%
Werbung
Evolent Health A Aktie Analyse
01.06.17 | Evolent Health A Outperform | Robert W. Baird & Co. Incorporated | |
13.07.16 | Evolent Health A Outperform | FBR Capital | |
29.03.16 | Evolent Health A Outperform | FBR Capital | |
06.01.16 | Evolent Health A Buy | Canaccord Adams |
Werbung
Werbung